Russian Federation vs South Africa: Share of S. aureus infections resistant to methicillin
Russian Federation
17.0%
in 2021
South Africa
16.5%
in 2022
Russian Federation rank
25th
South Africa rank
26th
Share of S. aureus infections resistant to methicillin over time
- Russian Federation
- South Africa
How they compare
Russian Federation currently reports 17.0% against 16.5% in South Africa, a difference of 0.5%.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was South Africa ahead.
Russian Federation ranks 25th and South Africa ranks 26th of 45 countries.
Across the 2 decades both report, Russian Federation averaged higher in 1 and South Africa in 1.
Head to head by decade
| Decade | Russian Federation | South Africa | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 19.1% | 23.2% | 4.2% | South Africa |
| 2020s | 23.0% | 18.1% | 4.8% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of s. aureus infections resistant to methicillin, Russian Federation or South Africa?
- Russian Federation, at 17.0% against 16.5% in South Africa as of 2021.
- What is the difference in share of s. aureus infections resistant to methicillin between Russian Federation and South Africa?
- 0.5%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and South Africa?
- 5 years are reported by both, from 2017 to 2021.
- How do Russian Federation and South Africa rank globally for share of s. aureus infections resistant to methicillin?
- Russian Federation ranks 25th and South Africa ranks 26th of 45 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of S. aureus infections resistant to methicillin. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%).